Kenya & Gilead Sciences

Kenya: Kenya has assessed a 'moderate risk of importation' of the Ebola virus and has formed a preparedness team, strengthening surveillance at all points of entry.

Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Kenya: Kenya>>> initially approved a plan for a quarantine facility for Ebola-exposed Americans but later faced a court order suspending the plan due to public health concerns and lack of public participation. The country is also seeking increased aid from the United States>>>.

Gilead Sciences: Gilead Sciences' antiviral remdesivir is mentioned as a potential treatment to be used at the quarantine facility, indicating its role in the medical response to Ebola.

Kenya: Kenya is where the US plans to open a quarantine center for Americans exposed to Ebola, a move that has drawn protests and concerns about burdening Kenya's health system.

Gilead Sciences: Gilead Sciences' experimental oral COVID antiviral drug, Obeldesivir, is being considered for use as a preventative treatment for Ebola contacts, under strict protocol.

Kenya: Hosts an MSF training center for Ebola response; US quarantine facility plans faced legal challenges.

Gilead Sciences: Developed obeldesivir, the antiviral being tested in the EBO-PEP trial.

Kenya: Continued to record progress in reducing HIV infections despite funding constraints.

Gilead Sciences: Facing pressure to expand access to lenacapavir; its pricing and licensing decisions are under scrutiny.

Kenya: Kenya>>> is one of ten African countries identified by the United States — Centers for Disease Control and Prevention>>> as being at elevated risk of Ebola transmission due to cross-border population movement.

Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.